The bold promise project: A system change in primary care to support cardiovascular risk screening in New Zealand

New Zealand Medical Journal

Volumn 119, Issue 1245, 2006, Pages

  Sinclair, Gary ^a,c   Kerr, Andrew ^b  

^a The Doctors Systems   (New Zealand)

^b MIDDLEMORE HOSPITAL   (New Zealand)

^c Division of Medicine Emergency and Integrated Care   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN;

ARTICLE; CALCULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; COHORT ANALYSIS; COMPUTER PROGRAM; DIABETES MELLITUS; FEMALE; GENERAL PRACTICE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; NEW ZEALAND; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; SCREENING; SYSTOLIC BLOOD PRESSURE;

EID: 33751100092     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ministry of Health. The New Zealand Health Strategy. Wellington: Ministry of Health; 2000. URL: http://www.moh.govt.nz/publications/nzhs
2. Ministry of Health. The primary health care strategy. Wellington: Ministry of Health; 2001. URL: http://www.moh.govt.nz/moh.nsf/0/ 7BAFAD2531E04D92CC2569E600013D04/$File/PHCStrat.pdf
3. New Zealand Guidelines Group, National Heart Foundation, Stroke Foundation, Ministry of Health. Best practice evidence-based guideline. The assessment and management of cardiovascular risk. Wellington: New Zealand Guidelines Group; 2003. URL: http://www.nzgg.org.nz/guidelines/ dsp_guideline_popup.cfm?guidelineCatID=32&guidelineID=35
4. Rafter N, Connor J, Hall J, et al. Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk. N Z Med J. 2005;118(1223). URL: http://www.nzma.org.nz/journal/118-1223/676
5. El-Jack S, Kerr A. Secondary prevention in coronary artery disease patients in South Auckland: moving targets and the current treatment gap. N Z Med J. 2003 Nov 7;116(1185).URL: http://www.nzma.org.nz/journal/ 116-1185/664
6. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293-8.
7. Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ. 2000 Mar 11;320:709-10.
8. Wellingham J, Tracey J, Rea H, Gribben B. The development and implementation of the Chronic Care Management Programme in Counties Manukau. N Z Med J. 2003;116(1169). URL: http://www.nzma.org.nz/journal/ 116-1169/327
9. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
10. Jackson G, Palmer C, Lindsay A, Peace J. Counties Manukau health profile. Manukau: Counties Manukau District Health Board; 2001.
11. Tipene-Leach D, Stewart A, Beaglehole R. Coronary heart disease mortality in Auckland Maori and Europeans. N Z Med J. 1991;104:55-7.
12. PHARMAC. PHARMAC Annual Review 2003. Wellington: PHARMAC; 2003.